drugset / Trial / NCT02762643
DP-R213 Pharmacokinetics Study
RandomizedCrossoverOpen-labelTreatment
Summary
A randomized, open-label, crossover, Phase I clinical trial to compare the pharmacokinetics of DP-R213 (Raloxifenel and Cholecaliferol fixed dose combinations) in comparison to each component administered alone in healthy male volunteers.
Timeline
- Start
- 2016-05
- Primary completion
- 2016-07
- Completion
- 2016-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cholecaliferol | Unknown | — | — |
| Subject | DP-R213 | Unknown | — | — |
| Subject | Raloxifene | Other / unclassified | — | — |
Indications
No indication recorded.